NCT00383591View on ClinicalTrials.gov

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

January 31, 2004

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B adjuvanted vaccine

BIOLOGICAL

Engerix-B

Trial Locations (5)

28046

GSK Investigational Site, Madrid

29010

GSK Investigational Site, Málaga

56000

GSK Investigational Site, Bandar Tun Razak, Cheras

500 01

GSK Investigational Site, Hradec Králové

08036

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00383591 - Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years | Biotech Hunter | Biotech Hunter